CHGCF - Chugai Pharmaceutical GAAP EPS of ¥227.57 revenue of ¥1.26B February, 02 2023 09:04 AM Chugai Pharmaceutical Chugai Pharmaceutical press release ( OTCPK:CHGCF ): FY GAAP EPS of ¥227.57. Revenue of ¥1.26B. For further details see: Chugai Pharmaceutical GAAP EPS of ¥227.57, revenue of ¥1.26B